Skip to content

News

 

2023 Life Science Review Award

CAMBRIDGE, MA, MARCH 2023: Matterworks has been recognized in the Top 10 Biotech Startups - 2023 by Life Science Review.

READ MORE

LSR 2023

JM Geremia

Matterworks Announces CEO Appointment and Board Updates

CAMBRIDGE, MA, DECMBER 2022: Matterworks, Inc., developers of the world's most powerful AI platform for modeling real-time biology to accelerate the discovery, development, and manufacturing of life sciences technologies, including biologics and gene therapies, today announces CEO appointment and updates to its Board of Directors.

READ MORE


Matterworks Awarded NIIMBL Project 5.2 Grant 

CAMBRIDGE, MA, AUGUST 2022: Matterworks is awarded a grant to participate in NIIMBL Project 5.2. With support from Eli Lilly and Sartorius our novel AI-powered Pyxis™ Metabolomics Platform will demonstrate biological insight in bioprocessing through the rapid, absolute quantitation of critical metabolites that impact titer and CQAs.

READ MORE

NIIMBL Logo-1

Lena & Eric-1

Matterworks Announces Updates To Its Board Of Directors

CAMBRIDGE, MA, APRIL 2022: Matterworks, Inc., developers of the world’s most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors.

READ MORE